₨ Official source-observed price
PKR 2,793.33
30's
PKR 93.11 / tablet
✓ Official DRAP price source observed · Source checked 2026-09-23
Price Intelligence
Equivalent price position
Same generic · strength · dosage form · compatible unitPrice Intelligence PRO →
This brandPKR 93.11/ tablet
Price position13% above medianvs like-for-like peer median
Peer comparators77current-price listings
🔒
MedInfoBase Pharma Pro
View Price Intelligence PRO
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Rank & percentilePeer medianFull competitor listPortfolio intelligence
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Empagliflozin
- Therapeutic area
- Endocrine & metabolic
- Drug class
- Antidiabetic medicines
- ATC
- A10BK
- Strength
- 10 mg
- Dosage form
- Tablet
- Pack
- 30's
- Registration no.
- 098697
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-09-23 03:18
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Traceability
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 2,793.33 | 2025-08-18 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Same generic
Other listed brands
ADRANCE 25 mgAtco Laboratories Limited · PKR 2,967.76ADRANCE 10 mgAtco Laboratories Limited · PKR 902.98ADRANCE 10 mgAtco Laboratories Limited · PKR 2,479.29ADRANCE 25 mgAtco Laboratories Limited · PKR 1,514.04ADRANCE 10 mgAtco Laboratories Limited · PKR 632.48ADRANCE 25 mgAtco Laboratories Limited · PKR 757.03ADRANCE 10 mgAtco Laboratories Limited · PKR 1,264.95ADRANCE 25 mgAtco Laboratories Limited · PKR 1,082.02
Evidence note: “Source observed” means MedInfoBase captured the record from an official DRAP source; it does not by itself mean the product registration was independently matched in the DRAP registry. Price note: Unit-price comparisons are informational calculations from official-source pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.
Cite this record
Medicine record · DRAP registration 098697MedInfoBase. (2026). Empagli 10 mg Tablet (30's), HIGH-Q Pharmaceuticals — registration and price record [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/brand/empagli-10-mg-098697-14s-high-q-pharmaceuticals/ Data observed 8 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 098697.
MedInfoBase. Empagli 10 mg Tablet (30's), HIGH-Q Pharmaceuticals — registration and price record [Internet]. Islamabad: MedInfoBase; 2026 [cited 2026 Sep 23]. Available from: https://medinfobase.com/brand/empagli-10-mg-098697-14s-high-q-pharmaceuticals/ Data observed 8 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 098697.
MedInfoBase (2026) Empagli 10 mg Tablet (30's), HIGH-Q Pharmaceuticals — registration and price record. Available at: https://medinfobase.com/brand/empagli-10-mg-098697-14s-high-q-pharmaceuticals/ (Accessed: 23 September 2026).
"Empagli 10 mg Tablet (30's), HIGH-Q Pharmaceuticals — registration and price record." MedInfoBase, 2026, https://medinfobase.com/brand/empagli-10-mg-098697-14s-high-q-pharmaceuticals/. Accessed 23 Sep 2026.
MedInfoBase. 2026. "Empagli 10 mg Tablet (30's), HIGH-Q Pharmaceuticals — registration and price record." Accessed September 23, 2026. https://medinfobase.com/brand/empagli-10-mg-098697-14s-high-q-pharmaceuticals/.
Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.